Related references
Note: Only part of the references are listed.Adipocyte Lipid Chaperone aP2 Is a Secreted Adipokine Regulating Hepatic Glucose Production
Haiming Cao et al.
CELL METABOLISM (2013)
Fatty acid binding protein 4 predicts left ventricular mass and longitudinal function in overweight and obese women
Stefan Engeli et al.
HEART (2013)
Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein
A. Toenjes et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Adipocyte-derived factors suppress heart contraction
C. Look et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
BMS309403 directly suppresses cardiac contractile function
Christiane Look et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Adipocyte Fatty Acid-Binding Protein Suppresses Cardiomyocyte Contraction A New Link Between Obesity and Heart Disease
Valeria Lamounier-Zepter et al.
CIRCULATION RESEARCH (2009)
Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells
Harun Elmasri et al.
FASEB JOURNAL (2009)
Mechanisms of regulated unconventional protein secretion
Walter Nickel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Adiponectin and leptin are secreted through distinct trafficking pathways in adipocytes
Linglin Xie et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Masato Furuhashi et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Structural basis for activation of fatty acid-binding protein 4
Richard E. Gillilan et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Masato Furuhashi et al.
NATURE (2007)
Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARγ by FABP4
Stephen D. Ayers et al.
BIOCHEMISTRY (2007)
Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity
Valeria Lamounier-Zepter et al.
FASEB JOURNAL (2006)
A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease
G Tuncman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Intracellular trafficking and secretion of adiponectin is dependent on GGA-coated vesicles
LL Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis
L Makowski et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice
JB Boord et al.
CIRCULATION (2004)
Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target
F Lehmann et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones:: a novel class of selective human A-FABP inhibitors
R Ringom et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages
YC Fu et al.
ATHEROSCLEROSIS (2002)
Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia
JB Boord et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
L Makowski et al.
NATURE MEDICINE (2001)
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation
M Wabitsch et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Improved glucose and lipid metabolism in genetically obese mice lacking aP2
KT Uysal et al.
ENDOCRINOLOGY (2000)
Share Paper
